NewsRx

Search our medical news database

Tumor Therapy

Study Optimizes Time Intervals For Administering Photodynamic Therapy

Published in Cancer Weekly, December 18th, 2001

by Sonia Nichols, senior medical writer - Researchers in Japan have determined the optimal time intervals for maximizing the efficacy of photodynamic therapy.

Photodynamic therapy is typically used for treating skin cancers and retinopathies, and is being investigated for the treatment of other tumors in a number of clinical trials. According to M. Uehara and associates at Nagasaki University School of Dentistry, photodynamic therapy (PDT) sessions for tumor treatment should be administered at least 24 hours apart. Because of cellular dynamics, shorter intervals between sessions are not as effective, they said in the European Journal of Cancer.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook